Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 3
Abstract
Objective To analyze the clinical and pathological factors affecting pathological complete response (pCR) of triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NAC). Methods A retrospective analysis was conducted in 78 TNBC patients treated with NAC and surgery in The First Affiliated Hospital of Xinjiang Medical University from January 2018 to September 2023. The patients were divided into pCR group (n=28) and non-pCR group (n=50) based on whether they had achieved pCR or not. Logistic regression analysis was used to investigate the clinical and pathological factors affecting pCR. The pCR rate and incidence of adverse reactions after NAC between TP regimen (taxane+platinum) and TAC regimen (taxane+anthracycline+cyclophosphamide) were compared. Results The overall pCR rate was 35.9%. There were statistically significant differences between the two groups of patients in tumor diameter, chemotherapy cycle, chemotherapy regimen, paclitaxel type, human epidermal growth factor receptor 2 (HER-2) expression, Ki-67 expression, and androgen receptor (AR) positive expression (P＞0.05). Multivariate logistic regression analysis showed that tumor diameter ≤ 3 cm was an independent favorable factor of pCR(OR=4.191, 95%CI: 1.246-14.094, P=0.021), and AR positive expression was an independent unfavorable factor of pCR (OR=0.124, 95%CI: 0.020-0.784, P=0.027). In addition, the pCR rate of the TP regimen was significantly better than that of the TAC regimen ［54.8%(17/31) vs 28.1%(9/32), χ2=4.636, P=0.031］, and there was no significant difference in the incidence of adverse reactions between two groups (P＞0.05). Conclusion TP or TAC regimen and albumin bound paclitaxel in NAC for TNBC is beneficial for achieving pCR status, but the pCR rate of TP regimen is better than that of TAC regimen, and the incidence of adverse reactions is comparable. The pCR rate is higher for tumor diameter≤3 cm, while low expression of HER-2, Ki-67, or AR indicates a lower pCR rate. AR positive expression is an independent unfavorable factor of pCR.
Authors and Affiliations
DUAN Shuai, Dilimulati Aisimutula, WANG Haiyan, GUO Chenming
Keywords
Related Articles
- EP ID EP734501
- DOI 10.13429/j.cnki.cjcr.2024.03.006
- Views 58
- Downloads 0
Impact of midwife-led experience delivery mode on the pregnancy outcomes of primiparas
"<b>Objective</b> To explore the clinical implementation of a midwife-led pregnancy experience delivery mode and its influence on the pregnancy outcome of primiparas. <b>Methods</b> A retrospective analysis was conduct...
Clinical efficacy of minimally invasive transforaminal lumbar interbody fusion and endoscopic lumbar interbody fusion in the treatment of lumbar degenerative diseases
<b>Objective</b> To compare the safety and clinical efficacy of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) and endoscopic lumbar interbody fusion (Endo-LIF) for lumbar degenerative diseases. <b...
Comparison of clinical efficacy between laparoscopic total gastrectomy and proximal gastrectomy in the treatment of adenocarcinoma of esophagogastric junction
<b>Objective</b> To compare the advantages and disadvantages of two different resection margins by observing the clinical efficacy of laparoscopic total gastrectomy (TG) and proximal gastrectomy(PG) for radical resection...
Expression and effect of P38 mitogen-activated protein kinase and transforming growth factor-β in gastric cancer
Gastric cancer is the most common malignant tumors in the upper digestive tract in the world. Although there are many treatment methods such as endoscopic resection, surgery, chemotherapy, targeted therapy, immunotherapy...
Diagnostic value of the combined detection of AFP and other three indexes in hepatocellular carcinoma related to hepatitis B virus
Objective To explore the clinical diagnostic value of combined serum alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-Ⅱ (PIVKA-Ⅱ), hepatic fibrosis 4 index (FIB-4) and tyrosine urine test (TUT)...